Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
25.25
+0.65 (2.64%)
Jun 12, 2026, 3:00 PM CST
Market Cap11.18B +57.1%
Revenue (ttm)1.00B +45.7%
Net Income98.39M
EPS0.24
Shares Out 442.94M
PE Ratio105.80
Forward PEn/a
Dividend0.06 (0.24%)
Ex-Dividend DateMay 14, 2026
Volume6,762,299
Open24.90
Previous Close24.60
Day's Range24.35 - 25.41
52-Week Range20.80 - 44.99
Beta0.68
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 1,002
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements